A Senate committee advanced a bipartisan bill prohibiting pharmacy benefit managers from clawing back certain payments or increasing fees to pharmacies in an effort to curb drug prices.
But some Republicans say the legislation shouldn’t move until the Federal Trade Commission, which has scrutinized the pharmaceutical industry middlemen, has more commissioners from their side of the aisle.
The pharmacy benefit managers bill (